Summary
- Veeva Systems is a cloud-based software solution provider for the pharmaceutical and life sciences industries.
- Veeva is valued at over $20 billion and is considered a top player in the industry, providing its services to hundreds of pharmaceutical and life sciences companies worldwide.
- Investors should also consider the potential impact of the company's relatively high stock-based compensation expense on net income and shareholder returns.
- For investors with a long-term horizon, we believe the company currently can be rated as a buy.
For further details see:
Veeva Systems: A Leading Provider Of Cloud-Based Solutions For The Pharmaceutical Industry